Abilify
This medication is formulated to address schizophrenia and manic episodes intended to support mental stability through balanced receptor modulation.
- Category
- Mental Health
- Active ingredient
- Aripiprazole
- Supply
- Rx
- Route
- Oral use
- Form
- Tablet
- Strengths
- 5 · 10 · 15 · 20 · 30mg
Abilify details
- Conditions
- Schizophrenia · Manic Episode
- Therapeutic class
- Second-Generation Antipsychotic
- Pharmacological class
- Atypical Antipsychotic
- Known off-label uses
- major depressive disorder
- Contraindications
- hypersensitivity to aripiprazole
- Minor side effects
- nausea; insomnia; dizziness
- Moderate side effects
- akathisia; tremor; fatigue
- Dosage forms
- Tablet
- Administration route
- Oral use
- Supply category
- Prescription only (specially controlled medicine)
- Manufacturer
- Otsuka
- Onset Time
- 1–2 weeks
- Duration
- 24 hours
- Storage instructions
- Store in original packaging below 30°C.
- Drug interactions
- Alcohol; Ketoconazole
- Age restrictions
- Not for use in children under 13 years old.
Precautions and warnings
may impair ability to drive or operate machinery; monitor for impulsive behavior; avoid overheating and dehydration
Serious side effects
neuroleptic malignant syndrome, requires immediate medical attention; tardive dyskinesia, requires immediate medical attention
Patient summary
This medication is formulated to address schizophrenia and manic episodes intended to support mental stability through balanced receptor modulation.
Mechanism of action
Aripiprazole acts as a partial agonist at dopamine D2 and serotonin 5-HT1A receptors, while acting as an antagonist at serotonin 5-HT2A receptors. This unique mechanism helps normalize dopamine activity in the brain.
Pregnancy and breastfeeding
Pregnancy: Use only if the potential benefit justifies the potential risk to the fetus. Breastfeeding: Not recommended; discuss alternatives with your doctor.
Where this medicine is registered
- Singapore
- Hong Kong
- Thailand
- Malaysia
- Philippines
- Indonesia
- Taiwan
- South Korea
- Japan
- Australia
- New Zealand
- UAE
- South Africa
About Abilify
Abilify is the brand-name formulation of aripiprazole, an antipsychotic medication used to manage symptoms of schizophrenia and manic episodes. Manufactured by Otsuka, this treatment is supplied as a tablet in strengths of 5mg, 10mg, 15mg, 20mg, and 30mg. It is intended to support patients in maintaining symptom stability for these psychiatric conditions.
Abilify availability in Asia
Abilify is registered across 14 markets including Hong Kong, Thailand and Malaysia, with availability also in the Philippines, Indonesia and Taiwan. For expats and people living far from a well stocked pharmacy, access to reliable medication is a priority. Generic aripiprazole provides an affordable alternative to the original brand, offering a consistent option for patients to manage their health across the region, though this medicine is best used under a doctor’s care.